dc.contributor.author |
Zanger, Philipp |
|
dc.date.accessioned |
2013-12-02T16:33:32Z |
|
dc.date.available |
2013-12-02T16:33:32Z |
|
dc.date.issued |
2013 |
|
dc.identifier.issn |
1560-7917 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/38541 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Eur Centre Dis Prevention & Control |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy - a research agenda for Europe |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20130911224530_00230 |
de_DE |
utue.publikation.seiten |
49-53 |
de_DE |
utue.personen.roh |
Zanger, P. |
|
utue.personen.roh |
Gabrysch, S. |
|
dcterms.isPartOf.ZSTitelID |
Eurosurveillance |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 20542 |
de_DE |
dcterms.isPartOf.ZS-Volume |
18 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |